These findings highlight the involvement of m6A modification, ANLN, specificity protein 1, and the kinesin family member 2C/mTORC1 pathway in the molecular mechanisms underlying bone metastasis in HCC.[64]. The gene discussed is ANLN; the disease is hepatocellular carcinoma.